Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.

Yang Q, Wang R, Wei B, Peng C, Wang L, Hu G, Kong D, Du C.

Biomed Res Int. 2018 Sep 26;2018:4246703. doi: 10.1155/2018/4246703. eCollection 2018.

2.

Methylation analysis of CMTM3 and DUSP1 gene promoters in high-quality brush hair in the Yangtze River delta white goat.

Qiang W, Guo H, Li Y, Shi J, Yin X, Qu J.

Gene. 2018 Aug 20;668:166-173. doi: 10.1016/j.gene.2018.05.031. Epub 2018 May 18.

PMID:
29783073
3.

miR-135b-5p promotes gastric cancer progression by targeting CMTM3.

Lu M, Huang Y, Sun W, Li P, Li L, Li L.

Int J Oncol. 2018 Feb;52(2):589-598. doi: 10.3892/ijo.2017.4222. Epub 2017 Dec 11.

PMID:
29345297
4.

DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.

Li J, Chen C, Bi X, Zhou C, Huang T, Ni C, Yang P, Chen S, Ye M, Duan S.

Gene. 2017 Sep 30;630:1-7. doi: 10.1016/j.gene.2017.07.082. Epub 2017 Aug 4.

PMID:
28782576
5.

Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.

Han T, Shu T, Dong S, Li P, Li W, Liu D, Qi R, Zhang S, Zhang L.

Oncol Lett. 2017 May;13(5):2982-2988. doi: 10.3892/ol.2017.5837. Epub 2017 Mar 10.

6.

CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.

Chrifi I, Louzao-Martinez L, Brandt M, van Dijk CGM, Burgisser P, Zhu C, Kros JM, Duncker DJ, Cheng C.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1098-1114. doi: 10.1161/ATVBAHA.116.308792. Epub 2017 Apr 20.

PMID:
28428220
7.

CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.

Yuan W, Liu B, Wang X, Li T, Xue H, Mo X, Yang S, Ding S, Han W.

Cancer Lett. 2017 Feb 1;386:77-86. doi: 10.1016/j.canlet.2016.11.015. Epub 2016 Nov 17.

PMID:
27867015
8.

Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.

Shen Z, Chen X, Li Q, Zhou C, Xu Y, Yu R, Ye H, Li J, Duan S.

Clin Biochem. 2016 Nov;49(16-17):1278-1282. doi: 10.1016/j.clinbiochem.2016.08.002. Epub 2016 Aug 10.

PMID:
27521994
9.

CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.

Li W, Zhang S.

Oncol Res. 2017 Jan 26;25(2):285-293. doi: 10.3727/096504016X14732523471442. Epub 2016 Sep 13.

PMID:
27629543
10.

[Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].

Hu FZ, Yuan WQ, Wang XL, Qin CP, Sheng ZZ, DU YQ, Yin HQ, Xu T.

Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Feb 18;48(1):594-7. Chinese.

11.

[Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].

Hu FZ, Yuan WQ, Wang XL, Qin CP, Sheng ZZ, DU YQ, Yin HQ, Xu T.

Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):594-597. Chinese.

12.

Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.

Hu FZ, Sheng ZZ, Qin CP, Xu T.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Jun 10;38(3):360-3. doi: 10.3881/j.issn.1000-503X.2016.03.022. Review.

13.

High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes.

Abe M, Yamashita S, Mori Y, Abe T, Saijo H, Hoshi K, Ushijima T, Takato T.

BMC Cancer. 2016 Jun 3;16:350. doi: 10.1186/s12885-016-2371-5.

14.

CMTM3 presents a secreted form released via exosomes.

Liu B, Li H, Fu W, Cheng Y, Yuan W, Liu W, Xue H, Mo X.

Acta Biochim Biophys Sin (Shanghai). 2016 Jun;48(6):584-6. doi: 10.1093/abbs/gmw029. Epub 2016 Apr 28. No abstract available.

15.

Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.

Yuan W, Li T, Mo X, Wang X, Liu B, Wang W, Su Y, Xu L, Han W.

Oncotarget. 2016 May 17;7(20):29507-19. doi: 10.18632/oncotarget.8789.

16.

The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription.

Abdel-Rahman WM, Lotsari-Salomaa JE, Kaur S, Niskakoski A, Knuutila S, Järvinen H, Mecklin JP, Peltomäki P.

Gastroenterol Res Pract. 2016;2016:6089658. doi: 10.1155/2016/6089658. Epub 2016 Mar 7.

17.

Re: CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis.

Richie JP.

J Urol. 2015 Sep;194(3):706-7. doi: 10.1016/j.juro.2015.06.010. Epub 2015 Jun 9. No abstract available.

PMID:
26292862
18.

CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.

Hu F, Yuan W, Wang X, Sheng Z, Yuan Y, Qin C, He C, Xu T.

Clin Transl Oncol. 2015 Aug;17(8):632-9. doi: 10.1007/s12094-015-1288-9. Epub 2015 May 20.

PMID:
25990505
19.

CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.

Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.

Tumour Biol. 2015 Sep;36(10):7849-58. doi: 10.1007/s13277-015-3504-1. Epub 2015 May 7.

PMID:
25946973
20.

Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.

Delic S, Thuy A, Schulze M, Proescholdt MA, Dietrich P, Bosserhoff AK, Riemenschneider MJ.

Genes Chromosomes Cancer. 2015 Jul;54(7):433-43. doi: 10.1002/gcc.22255. Epub 2015 Apr 30.

PMID:
25931111

Supplemental Content

Loading ...
Support Center